VIVE vs. STRR, HOLX, MDT, MASI, TMDX, ITGR, LIVN, CNMD, SLNO, and INMD
Should you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include Star Equity (STRR), Hologic (HOLX), Medtronic (MDT), Masimo (MASI), TransMedics Group (TMDX), Integer (ITGR), LivaNova (LIVN), CONMED (CNMD), Soleno Therapeutics (SLNO), and InMode (INMD).
Star Equity (NASDAQ:STRR) and Viveve Medical (NASDAQ:VIVE) are both small-cap multi-sector conglomerates companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, community ranking and risk.
Star Equity has higher revenue and earnings than Viveve Medical.
Viveve Medical received 308 more outperform votes than Star Equity when rated by MarketBeat users. However, 100.00% of users gave Star Equity an outperform vote while only 73.70% of users gave Viveve Medical an outperform vote.
Star Equity has a beta of 0.11, suggesting that its stock price is 89% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500.
3.8% of Star Equity shares are owned by institutional investors. 28.8% of Star Equity shares are owned by company insiders. Comparatively, 5.7% of Viveve Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
In the previous week, Star Equity had 1 more articles in the media than Viveve Medical. MarketBeat recorded 2 mentions for Star Equity and 1 mentions for Viveve Medical. Viveve Medical's average media sentiment score of 0.75 beat Star Equity's score of 0.00 indicating that Star Equity is being referred to more favorably in the media.
Star Equity has a net margin of 52.81% compared to Star Equity's net margin of 0.00%. Star Equity's return on equity of 0.00% beat Viveve Medical's return on equity.
Summary
Star Equity beats Viveve Medical on 9 of the 13 factors compared between the two stocks.
Get Viveve Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VIVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Viveve Medical Competitors List
Related Companies and Tools
Free VIVE Stock Alerts